IGF2BP1 is mainly localized in renal TECs [48]; thus, the IGF2BP1-mediated E2F1/MIF pathway in renal TECs may be a valuable target to mitigate septic acute kidney injury. The gene discussed is IGF2BP1; the disease is acute kidney injury.